Trademark Overview
On Tuesday, June 24, 2025, a trademark application was filed for NOVOSIS with the United States Patent and Trademark Office. The USPTO has given the NOVOSIS trademark a serial number of 99250754. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, June 24, 2025. This trademark is owned by CG Bio Co., Ltd.. The NOVOSIS trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Implants comprising living tissue; surgical transplants being living tissues; bone morphogenetic protein for use as a bone growth media; bone cement for surgical and orthopaedic purposes; bone growth media consisting of biological materials for medical purposes; bone fillers consisting of living materials; surgical implants comprised of living tissues; dental adhesives; bone cement for medical purposes; bone void fillers comprised of living tissues; human allogeneic tissue; medicinal preparation for preventing osteoporosis to facilitate bone growth; pharmaceutical preparations for the treatment of bone fractures to facilitate bone growth; syringes sold filled with pharmaceutical preparations to facilitate bone growth
Medical apparatus and instruments to facilitate bone growth; medical bone graft materials, namely, synthetic bone grafts; implants being prostheses for use in bone grafting, namely, bone substitutes for surgical use; artificial bones for implantation; artificial bone parts to be implanted in natural bones; injection device for pharmaceuticals to facilitate bone growth; bone void fillers comprised of artificial materials; bone implants composed of artificial materials; surgical bone cementation tools and equipment; substitutes for bones, cartilage, ligaments and tendons; dental implants made of artificial materials; artificial bone growth media; prosthetic and filling materials, namely, putty for use in the replacement of bones
